299916-62-4

• 常用中文名：7-N-苄氧基甲基-9-溴-9-去氮-6-O-甲基次黄嘌呤
• 常用英文名：5H-Pyrrolo3,2-dpyrimidine, 7-bromo-4-methoxy-5-(phenylmethoxy)methyl-
• CAS号：299916-62-4
• 分子式：C₁₅H₁₄BrN₃O₂
• 分子量：348.195
• 发布时间：2018-10-23 09:55:00
• 更新时间：2025-09-01 18:25:07

名称

• 中文名: 7-溴-4-甲氧基-5-[(苯基甲氧基)甲基]-5H-吡咯并[3,2-d]嘧啶
• 英文名: 5-[(Benzyloxy)methyl]-7-bromo-4-methoxy-5H-pyrrolo[3,2-d]pyrimidi ne
• 中文别名: 7-N-苄氧基甲基-9-溴-9-去氮-6-O-甲基次黄嘌呤
• 英文别名: 2,4-Diamino-6-methoxymethylpteridine; 6-methoxymethyl-pteridine-2,4-diamine; 5-[(Benzyloxy)methyl]-7-bromo-4-methoxy-5H-pyrrolo[3,2-d]pyrimidine; 2,4-Diamino-6-methoxymethylpteridin; 5H-Pyrrolo[3,2-d]pyrimidine, 7-bromo-4-methoxy-5-[(phenylmethoxy)methyl]-; 7-N-benzyloxymethyl-9-bromo-9-deaza-6-O-methylhypoxanthine

物化性质

• 密度: 1.5±0.1 g/cm3
• 沸点: 476.6±45.0 °C at 760 mmHg
• 分子式: C₁₅H₁₄BrN₃O₂
• 分子量: 348.195
• 闪点: 242.1±28.7 °C
• 精确质量: 347.026947
• PSA: 49.17000
• LogP: 3.63
• 蒸汽压: 0.0±1.1 mmHg at 25°C
• 折射率: 1.641
• 储存条件: 室温

合成路线

1026012-16-7 ~76% 299916-62-4

文献：BIOCRYST PHARMACEUTICALS, INC.; BABU, Yarlagadda, S.; KOTIAN, Pravin, L.; BANTIA, Shanta; WU, Minwan; KUMAR, V., Satish Patent: WO2014/78778 A2, 2014 ; Location in patent: Page/Page column 106-107 ;

5655-01-6 ~% 299916-62-4

文献：BIOCRYST PHARMACEUTICALS, INC.; BABU, Yarlagadda, S.; KOTIAN, Pravin, L.; BANTIA, Shanta; WU, Minwan; KUMAR, V., Satish Patent: WO2014/78778 A2, 2014 ;

84905-80-6 ~% 299916-62-4

文献：BIOCRYST PHARMACEUTICALS, INC.; BABU, Yarlagadda, S.; KOTIAN, Pravin, L.; BANTIA, Shanta; WU, Minwan; KUMAR, V., Satish Patent: WO2014/78778 A2, 2014 ;

180059-04-5 ~% 299916-62-4

文献：BIOCRYST PHARMACEUTICALS, INC.; BABU, Yarlagadda, S.; KOTIAN, Pravin, L.; BANTIA, Shanta; WU, Minwan; KUMAR, V., Satish Patent: WO2014/78778 A2, 2014 ;

779326-74-8 ~% 299916-62-4

文献：BIOCRYST PHARMACEUTICALS, INC.; BABU, Yarlagadda, S.; KOTIAN, Pravin, L.; BANTIA, Shanta; WU, Minwan; KUMAR, V., Satish Patent: WO2014/78778 A2, 2014 ;

上下游产品

上游产品  5
1026012-16-7 5655-01-6 84905-80-6 180059-04-5
779326-74-8
下游产品  0